# clm_5B0035249BB7

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: operating_income  
value: 4,047,100,000 United States dollar  
valid_from: 2023-12-31  
valid_to: 2024-12-31  
published: 2024-02-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_398CD3D76930  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals operating income: 4,047,100,000 United States dollar", as of 2023-12-31 (until 2024-12-31). Claim clm_5B0035249BB7, https://asof.is/claim/clm_5B0035249BB7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/0001804220-24-000009-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-K FY2023, filed 2024-02-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/0001804220-24-000009-index.htm (primary, SEC EDGAR 10-K FY2023, published 2024-02-05)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | 4,738,900,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_5B0035249BB7](/claim/clm_5B0035249BB7.md) | [clm_1DC3E40C4DC4](/claim/clm_1DC3E40C4DC4.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.